| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918738 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Changes in target coverage during treatment were small and considered clinically irrelevant. However, an overall increase in dose to the OARs was found as compared to the planned dose, which should be taken into account during treatment planning.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna M. Dinkla, Bradley R. Pieters, Kees Koedooder, Philip Meijnen, Niek van Wieringen, Rob van der Laarse, Johan N. van der Grient, Coen R.N. Rasch, Arjan Bel,